Lincomycin contains lincomycin, a lincosamide antibiotic used to treat serious infections caused by susceptible Gram-positive bacteria and anaerobic organisms. It works by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. Lincomycin is typically reserved for patients who cannot tolerate penicillin or where penicillin-resistant organisms are involved. Always use Lincomycin exactly as directed by your doctor.

Lincomycin contains lincomycin, a naturally derived lincosamide antibiotic produced by the actinobacterium Streptomyces lincolnensis. It is structurally and mechanistically related to clindamycin, which is a semi-synthetic derivative of lincomycin with improved pharmacokinetic properties.

Lincomycin binds specifically to the 50S subunit of bacterial ribosomes, inhibiting peptide chain elongation and halting bacterial protein synthesis. It is primarily bacteriostatic at standard concentrations but may exert bactericidal effects at higher concentrations against highly susceptible organisms.

Its spectrum of activity covers most Gram-positive cocci including Staphylococcus aureus and Streptococcus pyogenes, as well as anaerobic bacteria such as Bacteroides and Clostridium species. It has no clinically useful activity against Gram-negative aerobic organisms.

Lincomycin achieves good tissue penetration, including into bone, making it particularly useful in osteomyelitis and other deep-seated infections. It is available in oral and injectable formulations, with the injectable form used for serious systemic infections requiring higher and more reliable plasma concentrations.

The uses of Lincomycin are as follows:

Serious Gram-Positive Bacterial Infections

Lincomycin is used to treat serious infections of the respiratory tract, skin, soft tissue, and bone caused by susceptible Gram-positive organisms.

Osteomyelitis

Its good bone penetration makes it particularly useful in the treatment of bone infections.

Penicillin-Allergic Patients

It is used as an alternative in patients with known penicillin allergy requiring treatment for susceptible organisms.

Anaerobic Infections

It is used in infections involving anaerobic organisms including intra-abdominal and pelvic infections.

Septicaemia

Injectable lincomycin is used in serious systemic infections requiring parenteral antibiotic therapy.

Here are the benefits of Lincomycin:

• Good Bone and Tissue Penetration: Lincomycin achieves high concentrations in bone and deep tissues, making it effective in osteomyelitis and deep-seated infections.

• Penicillin Alternative: Provides effective treatment for Gram-positive and anaerobic infections in penicillin-allergic patients.

• Covers Anaerobic Organisms: Effective against clinically important anaerobes including Bacteroides and Clostridium species.

• Available in Injectable Form: Parenteral formulation ensures reliable plasma concentrations in serious systemic infections.

Like all medicines, Lincomycin may cause side effects in some individuals.

Common Side Effects

• Nausea and Vomiting: Gastrointestinal discomfort is the most frequently reported side effect with oral lincomycin.

• Diarrhoea: Loose stools may occur during treatment and should be monitored carefully.

• Abdominal Cramping: Mild abdominal discomfort may develop during the course of treatment.

Uncommon Side Effects

• Skin Rash: Mild hypersensitivity skin reactions may develop in some individuals.

• Altered Liver Enzymes: Mild transient elevations in liver function tests may occur.

• Glossitis or Stomatitis: Inflammation of the tongue or mouth lining may occur with prolonged use.

Serious Side Effects (Require Immediate Medical Attention)

• Clostridioides difficile Colitis: Severe or persistent diarrhoea during or after treatment may indicate antibiotic-associated colitis, which can be life-threatening.

• Severe Allergic Reaction: Swelling of the face, lips, or throat with difficulty breathing requires urgent medical care.

• Neuromuscular Blockade: High-dose or rapid intravenous administration may cause neuromuscular blockade, particularly in patients receiving muscle relaxants.

Always consult your doctor if side effects persist or worsen.

To ensure safe use:

• Use exactly as prescribed by your doctor.

• Oral formulations should be taken on an empty stomach for optimal absorption.

• Complete the full prescribed course even if symptoms improve early.

• Injectable formulations must be administered by a healthcare professional.

• Do not discontinue without consulting your doctor.

Lincomycin binds to the 23S RNA component of the 50S bacterial ribosomal subunit at the peptidyl transferase centre. This binding blocks peptide chain elongation by preventing the translocation of the ribosome along the mRNA, effectively halting bacterial protein synthesis.

At standard therapeutic concentrations this action is primarily bacteriostatic, inhibiting bacterial growth and replication while allowing the host immune system to clear the infection. At higher concentrations achieved with parenteral administration, bactericidal activity may occur against highly susceptible strains.

Lincomycin shares its ribosomal binding site with chloramphenicol and macrolide antibiotics, meaning concurrent use of these agents may result in competitive antagonism. Cross-resistance between lincomycin, clindamycin, and macrolides is also recognised.

A few practical measures can help ensure safe and effective use of Lincomycin:

• Take oral formulations on an empty stomach: Food significantly reduces the absorption of oral lincomycin; take at least one to two hours before or after meals.

• Complete the full course: Stopping treatment early may allow bacteria to survive and develop resistance, increasing the risk of treatment failure.

• Report persistent diarrhoea immediately: Diarrhoea during or after antibiotic treatment may indicate Clostridioides difficile colitis, a serious condition requiring prompt medical review.

• Inform your doctor of all medicines: Lincomycin shares its ribosomal target with chloramphenicol and macrolides; concurrent use may result in antagonism.

• Do not use antidiarrhoeal medicines without advice: If diarrhoea develops during treatment, do not self-medicate with antidiarrhoeals as this may worsen antibiotic-associated colitis.

Proper storage is important to maintain the stability and effectiveness of Lincomycin:

• Store at room temperature: Keep away from heat, moisture, and direct sunlight.

• Keep in original packaging: Protects tablets and injectable formulations from degradation.

• Keep out of reach of children: Store safely to prevent accidental ingestion.

• Check expiry before use: Do not use after the expiry date printed on the packaging.

Lincomycin may be affected by food intake. Therefore:

• Take on an empty stomach: Food significantly reduces oral lincomycin absorption; optimal intake is one to two hours before or after meals.

• Avoid excessive alcohol: May worsen gastrointestinal side effects during treatment.

• No other significant dietary restrictions apply: General nutritional intake does not require modification during lincomycin therapy.

Lincomycin may interact with the following medicines:

• Chloramphenicol and Macrolide Antibiotics: Compete for the same ribosomal binding site, potentially resulting in antagonism. Concurrent use should be avoided.

• Neuromuscular Blocking Agents: Lincomycin may enhance the effect of neuromuscular blocking drugs, increasing the risk of prolonged paralysis, particularly in surgical settings.

• Antidiarrhoeal Medicines (Loperamide): Concurrent use during antibiotic-associated colitis may worsen the condition by reducing bowel clearance of toxins.

• Kaolin-Pectin Antidiarrhoeals: May significantly reduce oral lincomycin absorption when taken simultaneously.

Lincomycin should be used carefully in the following conditions:

• History of Antibiotic-Associated Colitis: Lincomycin carries a significant risk of Clostridioides difficile colitis and should be avoided or used with extreme caution in patients with a prior history.

• Inflammatory Bowel Disease: Patients with ulcerative colitis or Crohn's disease are at higher risk of severe colitis with lincosamide antibiotics.

• Myasthenia Gravis: Lincomycin may worsen neuromuscular transmission impairment and is generally avoided in myasthenia gravis.

• Hepatic Impairment: Reduced hepatic metabolism may increase drug accumulation and side effect risk.

Dose and frequency depend on the severity of infection, the route of administration, and the prescribing doctor's recommendation. Oral doses are typically taken two to four times daily on an empty stomach as directed by your doctor.

If a dose is missed, take it as soon as remembered. Do not double the dose to make up for a missed one.